Corneal diameter negatively associated with central corneal thickness

Article

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery.

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery, according to a study published in the European Journal of Ophthalmology.

The investigation by Dr Ales Filous et al., Department of Ophthalmology for Children and Adults, Charles University, Prague, Czech Republic, involved 32 patients post-congenital cataract surgery with absolute microcornea (Group A), 13 patients with absolute microcornea without any history of eye surgery (Group B) and a control group of 124 healthy schoolchildren.

Patients with scars or corneal oedema were excluded from the study. Horizontal corneal diameter (HCD) was measured with calliper and CCT was recorded using an ultrasound pachymeter.

The findings demonstrated a significantly higher CCT of 635.13±65.35 µm and 642.31±93.07 µm, respectively in 48 eyes from group A and 16 eyes in Group B. This was compared to the mean CCT in the control group of 553.58±33.12 µm. A decrease in HCD and an increase in CCT were demonstrated by the regression curve in the microphthalmic eyes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.